Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy commerce e-commerce

	Profile	Recent Articles on Subject
1	James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales oceanjournalismauthorship	Magic mushrooms found in Africa are a species new to science - 8 days ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Psychedelics haven’t fulfilled clinical expectations, but new trial strategies could turn the tide - 11 days ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 6 months ago
3	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	4 Things Employers Should Know About Psychedelic Medicines - about 1 month ago What’s Next for Psychedelic Medicines? - about 2 months ago
4	Kristen Monaco MedPage Today	Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - about 1 month ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 4 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 4 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - 10 months ago Psychedelics for Psych Conditions Made Their Mark in 2023 - 12 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - about 1 year ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 4 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 4 months ago A tough week for MDMA-assisted psychotherapy - 4 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 4 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 4 months ago Psychedelic investment continues to ramp up - 10 months ago
6	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 4 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 4 months ago The Case for MDMA’s Approval Is Riddled With Problems - 7 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - 12 months ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Declines to Approve MDMA for PTSD - 4 months ago Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 8 months ago Is 2024 the Year for Psychedelic Medicine? - 9 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - 10 months ago
8	Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York consciousnesseconomicspodcasting	MDMA therapy didn’t get FDA approval. Now what? - 4 months ago Psychedelics are about to become a casualty of Oregon’s opioid crisis - 9 months ago China’s emerging psychedelic scene looks a lot like Silicon Valley - 10 months ago Robin Carhart-Harris studies psychedelics to understand the mind - about 1 year ago Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	The Promise of 'Magic Mushrooms' for Mental Health Is Real - 5 months ago
10	The Conversation Science Alert Science news. Official account. Australia science news	Scientists Reveal What Your Brain Looks Like on Psilocybin - 5 months ago

Journalists covering Psilocybin-Assisted Therapy